{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:54:56Z","timestamp":1794567296675,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":43,"publisher":"Springer New York","isbn-type":[{"value":"9781493978243","type":"print"},{"value":"9781493978250","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7825-0_13","type":"book-chapter","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T08:44:16Z","timestamp":1527756256000},"page":"241-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Minipigs as a Large-Brained Animal Model for Huntington\u2019s Disease: From Behavior and Imaging to Gene Therapy"],"prefix":"10.1007","author":[{"given":"Ralf","family":"Reilmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Schuldenzucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"13_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JHD-130050","volume":"2","author":"AJ Morton","year":"2013","unstructured":"Morton AJ, Howland DS (2013) Large genetic animal models of Huntington\u2019s disease. J Huntingtons Dis 2:3\u201319","journal-title":"J Huntingtons Dis"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1038\/mtna.2016.7","volume":"5","author":"J Miniarikova","year":"2016","unstructured":"Miniarikova J, Zanella I, Huseinovic A et al (2016) Design, characterization, and lead selection of therapeutic mirnas targeting huntingtin for development of gene therapy for Huntington\u2019s disease. Mol Ther Nucleic Acids 5:e297","journal-title":"Mol Ther Nucleic Acids"},{"key":"13_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JHD-130001","volume":"2","author":"M Baxa","year":"2013","unstructured":"Baxa M, Hruska-Plochan M, Juhas S et al (2013) A transgenic minipig model of Huntington\u2019s disease. J Huntingtons Dis 2:47\u201368","journal-title":"J Huntingtons Dis"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","volume":"63","author":"EH Aylward","year":"2004","unstructured":"Aylward EH, Sparks BF, Field KM et al (2004) Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63:66\u201372","journal-title":"Neurology"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR et al (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8:791\u2013801","journal-title":"Lancet Neurol"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1212\/WNL.0b013e3182020123","volume":"75","author":"N Bechtel","year":"2010","unstructured":"Bechtel N, Scahill RI, Rosas HD et al (2010) Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology 75:2150\u20132160","journal-title":"Neurology"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G et al (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12:637\u2013649","journal-title":"Lancet Neurol"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ, Reilmann R, Roos RA et al (2012) Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 11:42\u201353","journal-title":"Lancet Neurol"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2008","unstructured":"Paulsen JS, Langbehn DR, Stout JC et al (2008) Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 79:874\u2013880","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1474-4422(14)70238-8","volume":"13","author":"JS Paulsen","year":"2014","unstructured":"Paulsen JS, Long JD, Ross CA et al (2014) Prediction of manifest Huntington\u2019s disease with clinical and imaging measures: a prospective observational study. Lancet Neurol 13:1193\u20131201","journal-title":"Lancet Neurol"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/mds.26118","volume":"30","author":"A Sturrock","year":"2015","unstructured":"Sturrock A, Laule C, Wyper K et al (2015) A longitudinal study of magnetic resonance spectroscopy Huntington\u2019s disease biomarkers. Mov Disord 30:393\u2013401","journal-title":"Mov Disord"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","volume":"75","author":"A Sturrock","year":"2010","unstructured":"Sturrock A, Laule C, Decolongon J et\u00a0al (2010) Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology 75:1702\u20131710","journal-title":"Neurology"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/mds.26021","volume":"29","author":"C Sampaio","year":"2014","unstructured":"Sampaio C, Borowsky B, Reilmann R (2014) Clinical trials in Huntington\u2019s disease: interventions in early clinical development and newer methodological approaches. Mov Disord 29:1419\u20131428","journal-title":"Mov Disord"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/mds.26174","volume":"30","author":"R Reilmann","year":"2015","unstructured":"Reilmann R, Rouzade-Dominguez ML, Saft C et al (2015) A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington\u2019s disease. Mov Disord 30:427\u2013431","journal-title":"Mov Disord"},{"key":"13_CR15","unstructured":"Reilmann R, McGarry A, Landwehrmeyer GB et al (2017) Efficacy, safety, and tolerability of pridopidine in Huntington\u2019s disease (HD): results from the phase II dose-ranging study, Pride-HD. Mov Disord 32(Suppl S2):323\u2013324"},{"key":"13_CR16","volume-title":"Huntington disease","author":"R Reilmann","year":"2017","unstructured":"Reilmann R, Schubert R (2017) Motor outcome measures in Huntington disease clinical trials. In: Feigin A, Anderson KE (eds) Huntington disease. Elsevier B.V., New York"},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group (1996) Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Mov Disord 11:136\u2013142","journal-title":"Mov Disord"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/mds.26008","volume":"29","author":"DS Howland","year":"2014","unstructured":"Howland DS, Munoz-Sanjuan I (2014) Mind the gap: models in multiple species needed for therapeutic development in Huntington\u2019s disease. Mov Disord 29:1397\u20131403","journal-title":"Mov Disord"},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/mds.26026","volume":"29","author":"A Rosser","year":"2014","unstructured":"Rosser A, Svendsen CN (2014) Stem cells for cell replacement therapy: a therapeutic strategy for HD? Mov Disord 29:1446\u20131454","journal-title":"Mov Disord"},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jneumeth.2015.11.013","volume":"265","author":"S Schramke","year":"2016","unstructured":"Schramke S, Schuldenzucker V, Schubert R et al (2016) Behavioral phenotyping of minipigs transgenic for the Huntington gene. J Neurosci Methods 265:34\u201345","journal-title":"J Neurosci Methods"},{"key":"13_CR21","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/mds.21987","volume":"23","author":"AK Rao","year":"2008","unstructured":"Rao AK, Muratori L, Louis ED et al (2008) Spectrum of gait impairments in presymptomatic and symptomatic Huntington\u2019s disease. Mov Disord 23:1100\u20131107","journal-title":"Mov Disord"},{"key":"13_CR22","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/mds.22003","volume":"23","author":"YA Grimbergen","year":"2008","unstructured":"Grimbergen YA, Knol MJ, Bloem BR et al (2008) Falls and gait disturbances in Huntington\u2019s disease. Mov Disord 23:970\u2013976","journal-title":"Mov Disord"},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/mds.24908","volume":"27","author":"R Reilmann","year":"2012","unstructured":"Reilmann R, Rumpf S, Beckmann H et al (2012) Huntington\u2019s disease: objective assessment of posture\u2014a link between motor and functional deficits. Mov Disord 27:555\u2013559","journal-title":"Mov Disord"},{"key":"13_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1268","volume":"3","author":"AK Rao","year":"2011","unstructured":"Rao AK, Mazzoni P, Wasserman P, Marder K (2011) Longitudinal change in gait and motor function in pre-manifest Huntington\u2019s disease. PLoS Curr 3:RRN1268","journal-title":"PLoS Curr"},{"key":"13_CR25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hbm.21449","volume":"34","author":"RI Scahill","year":"2013","unstructured":"Scahill RI, Hobbs NZ, Say MJ et al (2013) Clinical impairment in premanifest and early Huntington\u2019s disease is associated with regionally specific atrophy. Hum Brain Mapp 34:519\u2013529","journal-title":"Hum Brain Mapp"},{"key":"13_CR26","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1002\/mds.23243","volume":"25","author":"R Reilmann","year":"2010","unstructured":"Reilmann R, Bohlen S, Klopstock T et al (2010) Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington\u2019s disease. Mov Disord 25:2195\u20132202","journal-title":"Mov Disord"},{"key":"13_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00702-013-1115-9","volume":"121","author":"S Skodda","year":"2014","unstructured":"Skodda S, Schlegel U, Hoffmann R, Saft C (2014) Impaired motor speech performance in Huntington\u2019s disease. J Neural Transm 121:399\u2013407","journal-title":"J Neural Transm"},{"key":"13_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00455-010-9302-4","volume":"26","author":"AW Heemskerk","year":"2011","unstructured":"Heemskerk AW, Roos RA (2011) Dysphagia in Huntington\u2019s disease: a review. Dysphagia 26:62\u201366","journal-title":"Dysphagia"},{"key":"13_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228","journal-title":"Lancet"},{"key":"13_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2741\/S355","volume":"5","author":"EM Dumas","year":"2013","unstructured":"Dumas EM, van den Bogaard SJ, Middelkoop HA, Roos RA (2013) A review of cognition in Huntington\u2019s disease. Front Biosci (Schol Ed) 5:1\u201318","journal-title":"Front Biosci (Schol Ed)"},{"key":"13_CR31","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26012","volume":"29","author":"CA Ross","year":"2014","unstructured":"Ross CA, Pantelyat A, Kogan J, Brandt J (2014) Determinants of functional disability in Huntington\u2019s disease: role of cognitive and motor dysfunction. Mov Disord 29:1351\u20131358","journal-title":"Mov Disord"},{"key":"13_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/jnnp-2011-301940","volume":"83","author":"JC Stout","year":"2012","unstructured":"Stout JC, Jones R, Labuschagne I et al (2012) Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 83:687\u2013694","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnagi.2014.00078","volume":"6","author":"JS Paulsen","year":"2014","unstructured":"Paulsen JS, Long JD, Johnson HJ et al (2014) Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study. Front Aging Neurosci 6:78","journal-title":"Front Aging Neurosci"},{"key":"13_CR34","doi-asserted-by":"publisher","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","volume":"19","author":"LA Lione","year":"1999","unstructured":"Lione LA, Carter RJ, Hunt MJ et al (1999) Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation. J Neurosci 19:10428\u201310437","journal-title":"J Neurosci"},{"key":"13_CR35","first-page":"219","volume":"14","author":"D Craufurd","year":"2001","unstructured":"Craufurd D, Thompson JC, Snowden JS (2001) Behavioral changes in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol 14:219\u2013226","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"13_CR36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JHD-140127","volume":"3","author":"CA Fisher","year":"2014","unstructured":"Fisher CA, Sewell K, Brown A, Churchyard A (2014) Aggression in Huntington\u2019s disease: a systematic review of rates of aggression and treatment methods. J Huntingtons Dis 3:319\u2013332","journal-title":"J Huntingtons Dis"},{"key":"13_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jneumeth.2015.11.017","volume":"265","author":"R Schubert","year":"2016","unstructured":"Schubert R, Frank F, Nagelmann N et al (2016) Neuroimaging of a minipig model of Huntington\u2019s disease: feasibility of volumetric, diffusion-weighted and spectroscopic assessments. J Neurosci Methods 265:46\u201355","journal-title":"J Neurosci Methods"},{"key":"13_CR38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1109\/TPAMI.2012.143","volume":"35","author":"H Wang","year":"2012","unstructured":"Wang H, Suh JW, Das SR et al (2012) Multi-atlas segmentation with joint label fusion. IEEE Trans Pattern Anal Mach Intell 35:611\u2013623","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"13_CR39","first-page":"27","volume":"7","author":"H Wang","year":"2013","unstructured":"Wang H, Yushkevich PA (2013) Multi-atlas segmentation with joint label fusion and corrective learning-an open source implementation. Front Neuroinform 7:27","journal-title":"Front Neuroinform"},{"key":"13_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jneumeth.2010.07.041","volume":"192","author":"S Saikali","year":"2010","unstructured":"Saikali S, Meurice P, Sauleau P et al (2010) A three-dimensional digital segmented and deformable brain atlas of the domestic pig. J Neurosci Methods 192:102\u2013109","journal-title":"J Neurosci Methods"},{"key":"13_CR41","first-page":"F-6","volume":"86693","author":"A Ghayoor","year":"2013","unstructured":"Ghayoor A, Vaidya JG, Johnson HJ (2013) Development of a novel constellation based landmark detection algorithm. Proc SPIE 86693:F-6","journal-title":"Proc SPIE"},{"key":"13_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q","volume":"42","author":"DK Jones","year":"1999","unstructured":"Jones DK, Horsfield MA, Simmons A (1999) Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 42:515\u2013525","journal-title":"Magn Reson Med"},{"issue":"Suppl 2","key":"13_CR43","first-page":"2S55","volume":"78","author":"S Schramke","year":"2015","unstructured":"Schramke S, Schubert R, Frank F et al (2015) The Libechov minipig as a large animal model for preclinical research in Huntington\u2019s disease\u00a0\u2013 thoughts and perspectives. Cesk Slov Neurol 78(Suppl 2):2S55\u20132S60","journal-title":"Cesk Slov Neurol"}],"container-title":["Methods in Molecular Biology","Huntington\u2019s Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7825-0_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T01:49:48Z","timestamp":1720316988000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7825-0_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493978243","9781493978250"],"references-count":43,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7825-0_13","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-7825-0","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}